Skip to main content

Mock James M's Form 4 filing

Moderna, Inc. (MRNA) · filed Sep 14, 2026

Accession no.
0001682852-26-000174
Filed
Sep 14, 2026, 4:25 PM ET
Trade date
Sep 10, 2026
Filing delay
4 days
Rule 10b5-1 plan
Checked

This filing lists 3 non-derivative transactions and 1 derivative transaction. Open-market sales total $4.69M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mock James MCIK 0001736359Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 10, 2026Common StockMOption exerciseAcquired+19,836$30.96+$614,122.5694,211Direct
Sep 10, 2026Common StockSSaleDisposed−19,836$134.49−$2,667,743.6474,375Direct
Sep 10, 2026Common StockSSaleDisposed−15,000$134.49−$2,017,35059,375Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Sep 10, 2026Common StockMOption exerciseDisposed−19,836$0.00$043,642Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)